ScholarIQanswers from OpenAlex & ORCID
F Mizorogi
ResearcherPublications, citations & collaboration network
F Mizorogi is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does F Mizorogi have?
ScholarIQindexed works
F Mizorogi has 21 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does F Mizorogi have?
ScholarIQcitation count
F Mizorogi has 274 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of F Mizorogi?
ScholarIQh-index
F Mizorogi has an h-index of 6 in OpenAlex.
What is the i10-index of F Mizorogi?
ScholarIQi10-index
F Mizorogi has an i10-index of 4 in OpenAlex.
What is the OpenAlex record for F Mizorogi?
ScholarIQopenalex
The OpenAlex for F Mizorogi is on the source record.
What are the most-cited papers on F Mizorogi?
ScholarIQmost cited works
Hepatitis C Virus Infection in Patients with B-cell Non-Hodgkin's Lymphoma.
F Mizorogi, Jun Hiramoto, Akiyo Nozato, Yoshifusa TAKEKUMA, Kazuo Nagayama, Teruji Tanaka, K Takagi
Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505
Kuniaki Itoh, T. Ohtsu, Haruhiko Fukuda, Yusuke Sasaki, Michinori Ogura, Y Morishima, Ting‐Chao Chou, Kohsuke Aikawa, Naokuni Uike, F Mizorogi, Tatsuharu Ohno, Shu‐ichi Ikeda, T. Sai, Masafumi Taniwaki, Fumiko Kawano, Miyuki Niimi, T Hotta, M Shimoyama, Kensei Tobinai
The Production of Colony-Stimulating Factors by Thyroid Carcinoma Is Associated with Marked Neutrophilia and Eosinophilia.
Tetsuya Nakada, Hiromitsu Sato, Fuyuhiko Inoue, F Mizorogi, Kazuo Nagayama, Teruji Tanaka
Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects
Setsuko Akizuki, F Mizorogi, Tomoo Inoue, Kazuki Sudo, Akihiro Ohnishi
Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301
T Takenaka, Kuniaki Itoh, Takayo Suzuki, Atae Utsunomiya, Shin Matsuda, Takaaki Chou, Toshiaki Sai, Masayuki Sano, Susumu Konda, Tatsuji Ohno, C Mikuni, Kijoh Deura, Takashi Yamada, F Mizorogi, H Nagoshi, Masao Tomonaga, Tomomitsu Hotta, Kohichi Kawano, Keitaro Tsushita, Masami Hirano, M Shimoyama, Lymphoma Study Group